Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Genetic Manipulation Resulting in Decreased Donor Chondroitin sulfate Synthesis Mitigates Gvhd Following Allogeneic Hematopoietic Cell Transplantation in a Murine Model.

Suguru Tamura, MD, Takashi Ushiki, MD PhD, Tatsuya Suwabe, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Kyoko Fuse, MD PhD, Yasuhiko Shibasaki, MD PhD, Miwako Narita, MD PhD, Michihiro Igarashi, MDPhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-137448

Published: 2020

Journal Articles

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Haiping He, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuaki Yokoyama, MD PhD, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD, Tonghua Yang, MD PhD, Tokiko Nagamura-Inoue, MD PhD

Blood (2019) 134 (Supplement_1): 5011.

https://doi.org/10.1182/blood-2019-125046

Published: 2019

Journal Articles

Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells

Tokiko Nagamura-Inoue, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuo Ogami, MT, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD

Blood (2019) 134 (Supplement_1): 3584.

https://doi.org/10.1182/blood-2019-128627

Published: 2019

Journal Articles

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

Yasuhiko Shibasaki, MD, Kenta Kobayashi, Tatsuya Suwabe, MD, Kyoko Fuse, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD

Blood (2019) 134 (Supplement_1): 3322.

https://doi.org/10.1182/blood-2019-124733

Published: 2019

Journal Articles

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Kyoko Fuse, MD, Tomoyuki Tanaka, MD PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5260.

https://doi.org/10.1182/blood-2018-99-113251

Published: 2018

Journal Articles

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Tatsuya Suwabe, MD, Kyoko Fuse, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD PhD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5712.

https://doi.org/10.1182/blood-2018-99-115844

Published: 2018

Journal Articles

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Kyoko Fuse, MD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 2044.

https://doi.org/10.1182/blood.V130.Suppl_1.2044.2044

Published: 2017

Journal Articles

Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT

Yasuhiko Shibasaki, MD PhD, Tatsuya Suwabe, MD, Shun Uemura, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Kyoko Fuse, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 4590.

https://doi.org/10.1182/blood.V130.Suppl_1.4590.4590

Published: 2017

Journal Articles

Evaluation of Liver Iron Deposition in Transfusion-Dependent Patients By Dual-Energy CT

Hironori Kobayashi, MD PhD, Norihiko Yoshimura, MD PhD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2016) 128 (22): 3619.

https://doi.org/10.1182/blood.V128.22.3619.3619

Published: 2016

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

Journal Articles

Imaging of Body Iron Stores in Transfusion-Dependent Patients By Liver Dual- Energy CT

Hironori Kobayashi, MD PhD, Norihiko Yoshimura, MD PhD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD PhD, Masato Moriyama, MD PhD, Jun Takizawa, MD, PhD, Miwako Narita, MD PhD, Hirohito Sone, MDPhD, Masayoshi Masuko, MD PhD

Blood (2014) 124 (21): 2677.

https://doi.org/10.1182/blood.V124.21.2677.2677

Published: 2014

Journal Articles

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Yasuhiko Shibasaki, MD PhD, Yoshinobu Seki, MD PhD, Tomoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Kyoko Fuse, MD, Takashi Kozakai, MD, Hironori Kobayashi, MD PhD, Takashi Ushiki, MD PhD, Takashi Abe, MD PhD, Toshio Yano, MD PhD, Masato Moriyama, MD PhD, Takashi Kuroha, MD PhD, Noriatsu Isahai, MD PhD, Jun Takizawa, MD, PhD, Miwako Narita, MD PhD, Satoru Koyama, MD PhD, Tatsuo Furukawa, MD PhD, Hirohito Sone, MDPhD, Masayoshi Masuko, MD PhD

Blood (2014) 124 (21): 2334.

https://doi.org/10.1182/blood.V124.21.2334.2334

Published: 2014

Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD

Blood (2013) 122 (21): 2744.

https://doi.org/10.1182/blood.V122.21.2744.2744

Published: 2013

Journal Articles

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Hiroshi Fujiwara, MD, PhD, Fumihiro Ochi, MD, Toshiki Ochi, MD, PhD, Hiroaki Asai, MD, PhD, Yukihiro Miyazaki, MD, PhD, Taichi Azuma, MD, PhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Miwako Narita, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2013) 122 (21): 144.

https://doi.org/10.1182/blood.V122.21.144.144

Published: 2013

Journal Articles

Redirected CD4 + T Cells towards HLA Class I-Restricted WT1 Epitope Successfully Display Multifactorial Helper Function for the Enhancement of Antileukemia Efficacy Mediated by Redirected T-Cell Based Immunocelltherapy.

Yukihiro Miyazaki, MD, Hiroshi Fujiwara, MD, PhD, Toshiki Ochi, MD, PhD, Sachiko Okamoto, PhD, Hiroaki Asai, MD, Junichi Mineno, PhD, Miwako Narita, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2012) 120 (21): 3153.

https://doi.org/10.1182/blood.V120.21.3153.3153

Published: 2012

Journal Articles

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Toyoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Takashi Kozakai, MD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Kazue Takai, MD, Yoshinobu Seki, MD, Masashi Kobayashi, MD, Koichi Nagai, MD, Hoyu Takahashi, MD, Kenji Kishi, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, Tadashi Koike, MD, Akira Shibata, MD

Blood (2012) 120 (21): 3751.

https://doi.org/10.1182/blood.V120.21.3751.3751

Published: 2012

Journal Articles

Essential Role of γδT Cells In Naturally Acquired Immunity to Falciparum Malaria

Tomoyo Kanda-Taniguchi, PhD, Kaiissar Md. Mannoor, PhD, Changchun Li, MD, PhD, Norihiro Watanabe, PhD, Akie Yamahira, Samlane Phompida, Miwako Narita, MD, PhD, Hisami Watanabe, PhD, Masuhiro Takahashi, MD

Blood (2010) 116 (21): 4877.

https://doi.org/10.1182/blood.V116.21.4877.4877

Published: 2010

NARROW

Genetic Manipulation Resulting in Decreased Donor Chondroitin sulfate Synthesis Mitigates Gvhd Following Allogeneic Hematopoietic Cell Transplantation in a Murine Model.

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT

Evaluation of Liver Iron Deposition in Transfusion-Dependent Patients By Dual-Energy CT

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Imaging of Body Iron Stores in Transfusion-Dependent Patients By Liver Dual- Energy CT

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Redirected CD4 + T Cells towards HLA Class I-Restricted WT1 Epitope Successfully Display Multifactorial Helper Function for the Enhancement of Antileukemia Efficacy Mediated by Redirected T-Cell Based Immunocelltherapy.

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Essential Role of γδT Cells In Naturally Acquired Immunity to Falciparum Malaria

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only